Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation

Cholangiocarcinoma is an aggressive, strongly chemoresistant liver malignancy. Leukemia inhibitory factor (LIF), an IL-6 family cytokine, promotes progression of various carcinomas. To investigate the role of LIF in cholangiocarcinoma, we evaluated the expression of LIF and its receptor (LIFR) in hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Morton, Stuart Duncan, Cadamuro, Massimiliano, Brivio, Simone, Vismara, Marta, Stecca, Tommaso, Massani, Marco, Bassi, Nicolò, Furlanetto, Alberto, Joplin, Ruth Elizabeth, Floreani, Annarosa, Fabris, Luca, Strazzabosco, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694885/
https://www.ncbi.nlm.nih.gov/pubmed/26296968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694885/
https://www.ncbi.nlm.nih.gov/pubmed/26296968

Ejemplares similares